Thomas Mandrup-Poulsen

Thomas Mandrup-Poulsen

Professor


  1. 2018
  2. Published

    Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice

    Besançon, A., Goncalves, T., Valette, F., Dahllöf, M. S., Mandrup-Poulsen, Thomas, Chatenoud, L. & You, S., 1 Feb 2018, In: Diabetologia. 61, 2, p. 389-398 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage

    Vestergaard, A. L., Bang-Berthelsen, C. H., Floyel, T., Stahl, J. L., Christen, L., Sotudeh, F. T., Horskjaer, P. D. H., Frederiksen, K. S., Kofod, F. G., Bruun, C., Berchtold, L. A., Storling, J., Regazzi, R., Kaur, S., Pociot, Flemming & Mandrup-Poulsen, Thomas, 27 Sep 2018, In: PLOS ONE. 13, 9, p. 1-22 22 p., e0203713 .

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 923693